Following a story · 2 updates
DEA telehealth rule at White House review
Nov 20, 2026 – Nov 21, 2026
-
Telehealth prescribing flexibilities end Dec 31
DEA and HHS extended telemedicine prescribing flexibilities for Schedule II to V drugs through December 31, 2026, while the permanent special registration final rule is projected for November 2026 and DEA reviews more than 6,400 comments.
Read this issue → -
DEA telehealth rule at White House review
The permanent DEA Special Registrations for Telemedicine final rule is reportedly under Office of Information and Regulatory Affairs review, with current controlled-substance telemedicine flexibilities running through December 31, 2026.
Read this issue →